MORFINO, PAOLO
MORFINO, PAOLO
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells]
2023-01-01 Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Emdin, Michele
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
2022-01-01 Morfino, P.; Aimo, A.; Panichella, G.; Rapezzi, C.; Emdin, M.
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
2022-01-01 Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Vergaro, Giuseppe; Emdin, Michele; Clerico, Aldo
Cardiovascular toxicity from therapies for light chain amyloidosis
2023-01-01 Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Chianca, Michela; Vergaro, Giuseppe; Cipolla, Carlo Maria; Fedele, Antonella; Emdin, Michele; Fabiani, Iacopo; Cardinale, Daniela
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
2023-01-01 Emdin, Michele; Morfino, Paolo; Crosta, Lucia; Aimo, Alberto; Vergaro, Giuseppe; Castiglione, Vincenzo
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
2023-01-01 Morfino, Paolo; Aimo, Alberto; Vergaro, Giuseppe; Sanguinetti, Chiara; Castiglione, Vincenzo; Franzini, Maria; Perrone, Marco Alfonso; Emdin, Michele
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
2023-01-01 Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Gálvez-Montón, Carolina; Emdin, Michele; Bayes-Genis, Antoni
Unmet needs in end-of-life care for heart failure patients
2024-01-01 Quattrone, Filippo; Aimo, Alberto; Zuccarino, Sara; Sole Morelli, Maria; Morfino, Paolo; Gioia, Angela; Passino, Claudio; Ferre, Francesca; Nuti, Sabina; Emdin, Michele
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] | 1-gen-2023 | Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Emdin, Michele | |
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis | 1-gen-2022 | Morfino, P.; Aimo, A.; Panichella, G.; Rapezzi, C.; Emdin, M. | |
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond | 1-gen-2022 | Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Vergaro, Giuseppe; Emdin, Michele; Clerico, Aldo | |
Cardiovascular toxicity from therapies for light chain amyloidosis | 1-gen-2023 | Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Chianca, Michela; Vergaro, Giuseppe; Cipolla, Carlo Maria; Fedele, Antonella; Emdin, Michele; Fabiani, Iacopo; Cardinale, Daniela | |
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis | 1-gen-2023 | Emdin, Michele; Morfino, Paolo; Crosta, Lucia; Aimo, Alberto; Vergaro, Giuseppe; Castiglione, Vincenzo | |
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy | 1-gen-2023 | Morfino, Paolo; Aimo, Alberto; Vergaro, Giuseppe; Sanguinetti, Chiara; Castiglione, Vincenzo; Franzini, Maria; Perrone, Marco Alfonso; Emdin, Michele | |
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy | 1-gen-2023 | Morfino, Paolo; Aimo, Alberto; Castiglione, Vincenzo; Gálvez-Montón, Carolina; Emdin, Michele; Bayes-Genis, Antoni | |
Unmet needs in end-of-life care for heart failure patients | 1-gen-2024 | Quattrone, Filippo; Aimo, Alberto; Zuccarino, Sara; Sole Morelli, Maria; Morfino, Paolo; Gioia, Angela; Passino, Claudio; Ferre, Francesca; Nuti, Sabina; Emdin, Michele |